Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-05

Clinical Trial Update: Oral Polypodium Leucotomos for Melasma [NA]

View source ↗

Summary

A clinical trial evaluating oral Polypodium leucotomos extract for melasma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polypodium leucotomos extract (Polypodium leucotomos extract)

Snippet

Sponsor: University of Miami | Conditions: Melasma | NA | Status: COMPLETED